Skip to main content
. 2020 Feb 26;7:2054358120907816. doi: 10.1177/2054358120907816

Table 1.

Baseline Demographics and Presenting Symptoms of Patients Included in This Cohort of 44 Hemodialysis Patients Tested for Influenza Between November 1, 2017 and March 31, 2018, Stratified by Testing Platform.

Variable Rapid PCR (n = 14) Standard of care PCR (n = 30) P-value
Age—years (mean [SD]) 71.0 (10.8) 67.6 (15.1) .61
Sex (%) 1.00
 Female 5 (35.7) 12 (40.0)
 Male 9 (64.3) 18 (60.0)
Duration of dialysis therapy—years
(mean [SD])
3.64 (3.12) 3.32 (3.61) .84
Cause of end-stage kidney disease (%) .49
 Hypertension 2 (14.3) 3 (10.0)
 Diabetes 3 (21.4) 13 (43.3)
 Glomerulonephritis 5 (35.7) 5 (16.7)
 Other 4 (28.6) 4 (13.3)
Influenza vaccination in past year (%) .54
 Yes 13 (92.9) 29 (96.7)
 No 1 (7.1) 1 (3.3)
Symptoms present at presentation (%)
 Cough 13 (92.9) 20 (66.7) .08
 Fever 1 (7.1) 7 (23.3) .40
 Shortness of breath 3 (21.4) 8 (26.7) 1.0
 Malaise 2 (14.3) 5 (16.7) 1.0
 Other symptomsa 1 (7.1) 5 (16.7) .65

Note. PCR = polymerase chain reaction; SD = standard deviation.

a

Other symptoms reported included nasal discharge, rigors, wheeze, and sore throat.